Figure 3: Expression analysis of FAP, Col1A1, and TENASCIN desmoplastic markers in Thyroid MSCs and PTC MSCs.

(A–O) The qRT-PCR data demonstrated significantly increased desmoplastic marker expression in all five patient-derived PTC MSC samples compared to their non-carcinogenic thyroid counterparts. (A–C) Patient 1, (D–F) Patients 2, (G–I) Patient 3, (J–L) Patient 4, and (M–O) Patient 5. The p-values (*p < 0.05, **p < 0.01, ***p < 0.001) were determined by two-tail independent samples t-tests.